Under construction – not a live service
Sign in
Taking people in PakistanNo phase

Mirror Therapy Versus Motor Imagery for Arm Recovery After Middle Cerebral Artery Stroke

Compares two added exercise methods for arm movement in people after stroke.

Plain-language title generated from the registry record
Registry title: Effects of Mirror Therapy and Motor Imagery on Upper Limb Motor Functions in Middle Cerebral Artery Stroke

Key facts

Where
Lahore, PakistanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 45 and 65 years old?

Source: NCT07902284, who can take part

Where in Pakistan

  • Alfalah Medical CenterLahore, PakistanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Lahore University of Biological and Applied Sciences
Trial code
NCT07902284
Record updated
28 October 2026
Original description
This study will compare mirror therapy (MT) with motor imagery (MI), each added to routine Bobath-based physical therapy, to assess upper limb motor function and functional independence in patients with subacute middle cerebral artery (MCA) stroke. Upper limb dysfunction is a common and disabling consequence of MCA stroke, affecting reaching, grasping, manipulation and daily activities. Although MT and MI have each shown benefit, it is unclear which adjunct gives greater and longer-lasting improvement. A total of 36 adults aged 45-60 years will be randomly allocated 1:1 into an MT group or an MI group. Both groups will receive 3 supervised sessions per week for 6 weeks, followed by a 6-week home exercise program. Outcomes (Fugl-Meyer Assessment-Upper Extremity, Action Research Arm Test, Box and Block Test, Modified Barthel Index) will be assessed at baseline, post-intervention (Week 6) and follow-up (Week 12). The study aims to determine which intervention gives superior improvement in upper limb recovery.Read full original descriptionShow less

Effects of Mirror Therapy and Motor Imagery on Upper Limb Motor Functions in Middle Cerebral Artery Stroke

This study will compare mirror therapy (MT) with motor imagery (MI), each added to routine Bobath-based physical therapy, to assess upper limb motor function and functional independence in patients with subacute middle cerebral artery (MCA) stroke. Upper limb dysfunction is a common and disabling consequence of MCA stroke, affecting reaching, grasping, manipulation and daily activities. Although MT and MI have each shown benefit, it is unclear which adjunct gives greater and longer-lasting improvement. A total of 36 adults aged 45-60 years will be randomly allocated 1:1 into an MT group or an MI group. Both groups will receive 3 supervised sessions per week for 6 weeks, followed by a 6-week home exercise program. Outcomes (Fugl-Meyer Assessment-Upper Extremity, Action Research Arm Test, Box and Block Test, Modified Barthel Index) will be assessed at baseline, post-intervention (Week 6) and follow-up (Week 12). The study aims to determine which intervention gives superior improvement in upper limb recovery.

Inclusion: Patients of both genders aged 45-60 years; First-ever middle cerebral artery (MCA) stroke (ischemic or hemorrhagic) confirmed by CT/MRI; Stroke duration of 1-6 months; Presence of unilateral upper limb motor impairment; Brunnstrom stage II and above; Fugl-Meyer Assessment Upper Extremity (FMA-UE) score < 47; Montreal Cognitive Assessment (MoCA) > 24; Medically stable; Willing and able to provide written informed consent.

Exclusion: Visual impairment or unilateral neglect; Severe cognitive impairment or depression; Other neurological disorders; Severe musculoskeletal disorders of the upper limb; Serious uncontrolled medical conditions; Pre-existing upper limb dysfunction; Severe spasticity (Modified Ashworth Scale > 3); Participation in another clinical trial; Refusal or inability to provide.

ClinicalTrials.gov NCT07902284